Cancer testis antigens: A new paradigm for cancer therapy. Oncoimmunology 2012 Oct 01;1(7):1194-1196
Date
11/22/2012Pubmed ID
23170277Pubmed Central ID
PMC3494643DOI
10.4161/onci.20686Scopus ID
2-s2.0-84872648991 (requires institutional sign-in at Scopus site) 44 CitationsAbstract
Cancer immunotherapy is a promising field with limited success, also due to lack of tumor-specific targets. In our attempt of exploring novel biomarkers and immunotherapeutic targets against cancer, we have discovered a novel cancer testis antigen, SPAG9, in cancers of different histological origin and demonstrated its potential role in oncogenesis.